Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$41.91 - $50.48 $310,134 - $373,552
7,400 Added 117.46%
13,700 $683,000
Q3 2022

Nov 14, 2022

BUY
$40.9 - $50.42 $257,670 - $317,646
6,300 New
6,300 $260,000
Q2 2022

Aug 15, 2022

SELL
$42.98 - $49.77 $2.88 Million - $3.34 Million
-67,100 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$42.23 - $54.3 $2.83 Million - $3.64 Million
67,100 New
67,100 $3.36 Million
Q4 2021

Feb 14, 2022

SELL
$50.62 - $56.47 $1.51 Million - $1.69 Million
-29,900 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$46.55 - $56.83 $195,510 - $238,686
4,200 Added 16.34%
29,900 $1.54 Million
Q2 2021

Aug 06, 2021

BUY
$46.28 - $52.75 $282,308 - $321,775
6,100 Added 31.12%
25,700 $1.27 Million
Q1 2021

May 14, 2021

BUY
$46.25 - $56.02 $906,500 - $1.1 Million
19,600 New
19,600 $939,000
Q3 2020

Nov 13, 2020

SELL
$42.51 - $52.42 $824,694 - $1.02 Million
-19,400 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$39.49 - $44.36 $1.28 Million - $1.44 Million
-32,500 Reduced 62.62%
19,400 $837,000
Q1 2020

May 11, 2020

SELL
$33.17 - $41.6 $2.1 Million - $2.63 Million
-63,300 Reduced 54.95%
51,900 $2.1 Million
Q4 2019

Feb 12, 2020

BUY
$25.41 - $43.1 $2.33 Million - $3.95 Million
91,600 Added 388.14%
115,200 $3.88 Million
Q3 2019

Nov 14, 2019

BUY
$32.73 - $40.81 $772,427 - $963,116
23,600 New
23,600 $775,000
Q4 2018

Feb 14, 2019

SELL
$32.65 - $37.95 $264,465 - $307,395
-8,100 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$35.99 - $39.39 $291,519 - $319,059
8,100 New
8,100 $307,000
Q1 2018

May 15, 2018

SELL
$31.01 - $34.72 $369,019 - $413,168
-11,900 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$30.68 - $35.37 $365,092 - $420,902
11,900
11,900 $368,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.46B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.